Overview
Legal name
NALIA SYSTEMS LIMITED
Region
South West England
Registered address
Unknown
Insolvency history
No
Company
Active
LTD
Company profile
Nalia Systems Limited
Customisable Immunodiagnostic Biomarker Panels | NALIA Systems
NALIA Systems is a developer of customisable immunodiagnostic systems, in the form of biomarker panels, that accelerate drug discovery and development
CRN
05428896
Founded
2005
Age
20
Company events
Reference milestones and recent Companies House filing stream events.
2 events
22 Oct
2024
Gazette Dissolved Voluntary
GazetteGAZ2(A) | Transaction MzQzOTYzODkwNGFkaXF6a2N4 | Paper/PDF filed
Published 18 Oct 2024 01:07
19 Apr
2005
Incorporated
InceptionCompany registered at Companies House
Public funding
1 award
First funded
2015
Funded years
2015
Age at first award
10 years
Projects
2015
GRD Proof of Market
Lead participant
Point of Care Testing for Autoimmune Disorders
1 Dec 2015 to 31 Mar 2016
Awarded
£24,675
Total cost £41,126
Autoimmune diseases result from a dysfunction of the immune system; the body produces an immune response against its own tissues, and attacks its own organs, tissues, and cells. There are >80 types of autoimmune disorders, including thyroid and coeliac disease. Nalia have identified an opportunity to develop a rapid, cost-effective immunoassay which detec...
Product types
GRD Proof of Market